The development of technology of Fludeoxyglucose (18F) for injection, laboratory analysis methods

Journal Title: Фармацевтичний журнал - Year 2017, Vol 1, Issue 1

Abstract

18F-Fluorodeoxyglucose has optimal characteristics for use in nuclear medicine and is a priority among radiopharmaceuticals for the diagnosis of cancer by positron emission tomography (PET). 18F-Fluorodeoxyglucose has the longest half-life with the lowest energy of radiation, it allows to obtain PET images of high contrast at low dose loading on the patient. Low energy positron radiation provides high spatial resolution of PET images. However, the half-life of 18F-Fluorodeoxyglucose is large enough to allow the transportation of radiopharmaceuticals from the centralized production site to diagnostic centers with PET scanners (the so-called PET satellite concept), and to extend the time limits of PET research and synthesis of radiopharmaceuticals [1]. The study is the development of technology and quality control methods to ensure quality at all stages of the production of radiopharmaceuticals 18F-Fluorodeoxyglucose, injection. There was justified 18F-Fluorodeoxyglucose production technology and quality control at all stages of production, based on complex research in the department producing radiopharmaceuticals Ukrainian Center of radiosurgery consisting Clinical Hospital «Feofaniya». Object of study – 18F-Fluorodeoxyglucose, injection, injection is used in nuclear medicine for PET diagnosis of cancer. We used the biopharmaceutical and pharmaceutical methods. For the first time based pharmaceutical research was the rational technology of diagnostic radiopharmaceuticals 18F-Fluorodeoxyglucose, injection for use in PET diagnosis of cancer patients. Methods of controlling drug 18F-Fluorodeoxyglucose, injection according monographs of the State Pharmacopoeia of Ukraine. On the basis of the analysis developed by established methods of control performance specifications and shelf life of radiopharmaceuticals 18F-Fluorodeoxyglucose, injection.

Authors and Affiliations

V. V. Kachaniuk, S. Y. Sarychev

Keywords

Related Articles

Technology administration active substance in the ointment base

The problem of expanding the range of medicines that are used for the topical treatment of wound process, remains an important challenge for practical military medicine. In this aspect, there are topical ointments combin...

Hepatoprotective activity of 1,2,4-triazole-3-thione derivatives, which contains on c5-atomic carbon hydroxy(phenyl)methyl dependent

Relevance of pharmaceuticals with high efficiency and low cost for the prevention and treatment of diseases of the digestive system is unquestionable. It would be appropriate to mention that we carried out an analysis of...

Spectral characteristics and electronic structures of synthetic derivatives of coumarin. P a r t III. Pharmacophore and chemical-pharmacology structure of bicoumarin and ethylbiscoumacetas (neodicoumarine)

Most widely used in clinical practice enteral anticoagulants among which common dicoumarin and ehtilbiscoumacetas (neodicoumarin) are the structural derivatives of 4-hydroxycoumarin – compounds isolated from sweet clover...

Determination of the list of narcotic analgesics for providing population in conditions of emergency situations

The current state of natural, technological and socio-political safety of Ukraine determines the urgency and necessity of improvement the efficiency of the pharmaceutical supply of the population at liquidation of conseq...

Theoretical and experimental substantiation of the composition of the gel with the anti-inflammatory and local anesthetic action for application in sports medicine

The use of compounds of the natural origin, in particular standardized substances of propolis in combination with local anesthetics in the composition of soft dosage forms results in more expressed anti-inflammatory and...

Download PDF file
  • EP ID EP554018
  • DOI 10.32352/0367-3057.1.17.07
  • Views 65
  • Downloads 0

How To Cite

V. V. Kachaniuk, S. Y. Sarychev (2017). The development of technology of Fludeoxyglucose (18F) for injection, laboratory analysis methods. Фармацевтичний журнал, 1(1), 51-58. https://europub.co.uk/articles/-A-554018